Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis

An increased risk for thromboembolism in cancer patients has been observed in patients with solid tumours, whereas little data exist on malignant lymphoma. We found an overall thromboembolic event incidence of 7.7% in 1038 lymphoma patients treated in our institution, with a statistically significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohren, M, Markmann, I, Jentsch-Ullrich, K, Koenigsmann, M, Lutze, G, Franke, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826296/
https://www.ncbi.nlm.nih.gov/pubmed/15798767
http://dx.doi.org/10.1038/sj.bjc.6602504
_version_ 1784647400904720384
author Mohren, M
Markmann, I
Jentsch-Ullrich, K
Koenigsmann, M
Lutze, G
Franke, A
author_facet Mohren, M
Markmann, I
Jentsch-Ullrich, K
Koenigsmann, M
Lutze, G
Franke, A
author_sort Mohren, M
collection PubMed
description An increased risk for thromboembolism in cancer patients has been observed in patients with solid tumours, whereas little data exist on malignant lymphoma. We found an overall thromboembolic event incidence of 7.7% in 1038 lymphoma patients treated in our institution, with a statistically significantly higher incidence in high-grade than in low-grade lymphoma.
format Online
Article
Text
id pubmed-8826296
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-88262962022-03-15 Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis Mohren, M Markmann, I Jentsch-Ullrich, K Koenigsmann, M Lutze, G Franke, A Br J Cancer Short Communication An increased risk for thromboembolism in cancer patients has been observed in patients with solid tumours, whereas little data exist on malignant lymphoma. We found an overall thromboembolic event incidence of 7.7% in 1038 lymphoma patients treated in our institution, with a statistically significantly higher incidence in high-grade than in low-grade lymphoma. Nature Publishing Group 2005-04-25 2005-03-29 /pmc/articles/PMC8826296/ /pubmed/15798767 http://dx.doi.org/10.1038/sj.bjc.6602504 Text en Copyright © 2005 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Short Communication
Mohren, M
Markmann, I
Jentsch-Ullrich, K
Koenigsmann, M
Lutze, G
Franke, A
Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis
title Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis
title_full Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis
title_fullStr Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis
title_full_unstemmed Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis
title_short Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis
title_sort increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826296/
https://www.ncbi.nlm.nih.gov/pubmed/15798767
http://dx.doi.org/10.1038/sj.bjc.6602504
work_keys_str_mv AT mohrenm increasedriskofthromboembolisminpatientswithmalignantlymphomaasinglecentreanalysis
AT markmanni increasedriskofthromboembolisminpatientswithmalignantlymphomaasinglecentreanalysis
AT jentschullrichk increasedriskofthromboembolisminpatientswithmalignantlymphomaasinglecentreanalysis
AT koenigsmannm increasedriskofthromboembolisminpatientswithmalignantlymphomaasinglecentreanalysis
AT lutzeg increasedriskofthromboembolisminpatientswithmalignantlymphomaasinglecentreanalysis
AT frankea increasedriskofthromboembolisminpatientswithmalignantlymphomaasinglecentreanalysis

Ejemplares similares